Title
Approving a resolution regarding joining in the national opioids Secondary Manufacturers Settlements.
Summary
The proposed settlement requires Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus to pay an estimated $45 million to Texas and its political subdivisions. Distributions within Texas is governed by the Texas Term Sheet, an intrastate agreement between the state and litigating subdivisions. The more subdivisions that join the settlements, the more money everyone in Texas will receive. The funding must be used to support ay of a wide variety of strategies to fight the opioid crisis. Based on the participation forms received, the subdivision participation rate will be used to determine whether participation is sufficient for the settlement and whether a state earns its maximum potential payment. The City of Pflugerville has received about $57,000 from previous opioid settlements.
Prior City Council Action
City Council approved Resolution 1908-21-09-14-0916 on September 14, 2021 adopting the Texas Term Sheet and joining the Distributors and J&J settlements.
City Council approved Resolution 1953-22-03-08-0970 on March 8, 2022 joining the Teva and Endo settlements.
City Council approved Resolution 2031-23-03-14-1085 on March 14, 2023 joining Allergen, CVS, Walgreens, and Walmart settlements.
City Council approved Resolution 2178-24-12-10-1292 on December 10, 2024 joining Kroger settlement.
City Council approved Resolution 2209-25-08-12-1338 on August 12, 2025 joining Purdue settlement.
Deadline for City Council Action
October 9, 2025
Funding Expected: Revenue _X_ Expenditure __ N/A __
Budgeted Item: Yes __ No __ N/A _X_
Budget Source: Special Revenue Fund
Amount: N/A
1295 Form Required? Yes __ No _X_
Legal Review Required: N/A __ Required _X_ Date Completed: July 31, 2025
Supporting documents attached:
Secondary Manufacturers Opioid Settlement Resolution
Secondary Manufacturers Opioid Settlement Information Sheet and Participation Form
Recommended Action
Approving a resolution regarding joining in the national opioids Secondary Manufacturers Settlements.